Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jul
1
2011
 Report From Bio International Convention in DC– Everyone In the Patent Pool!
Mar
26
2012
 Supreme Court Remands In Myriad Appeal
Apr
17
2012
 Supreme Court Reverses In Caraco Appeal
Jun
28
2012
 Lilly Files Amicus Brief in Myriad Remand – With Friends Like This…
Sep
26
2012
 Personalized Medicine Takes Off While Diagnostic Assays are Grounded
May
1
2018
 How The Fanapt Product Label Established Infringement Of Personalized Treatment Claims
Jul
10
2013
 Supreme Court Decision Myriad Brings Out Its “Reserve Claims” To Challenge Ambry Re: Patent Eligibility
Aug
21
2013
 Review of Indian Patent Working Requirements
Jul
16
2018
 Health Care Policy Newsletter: Week of July 9, 2018
Jul
23
2018
 Interval Licensing v. AOL — Judge Plager’s Concurring Dissent
Oct
16
2021
 CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”?
Dec
20
2014
 Myriad's Breast Cancer Test Patents Not Patent Eligible
Feb
10
2016
 FDA Unveils Action Plan to Combat Opioid Abuse
Jul
8
2016
 FDA Releases Outline of Guidance for Developing Tests Based on Human Genetic Variants
Oct
7
2023
 The Tyranny of Large Numbers: Their Grip on s. 102 Inquiries
Jun
22
2020
 Biogen v. Mylan: When Does a Specification Fail to Describe a Newly-Presented Claim?
Jun
28
2012
 “Obamacare” Survives – Including Path to Generic Biologicals
Jul
2
2014
 More Questions Than Answers from the Patent and Trademark Office (PTO)
Apr
4
2019
 Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law?
May
25
2022
 Medicare Advantage: OIG Report Finds Improper Denials
Aug
17
2022
 Hearing Aids: More Accessible to Consumers After FDA Issues Final Rule
Mar
11
2015
 Regulation of Chemicals in Consumer Products on the Rise
Aug
26
2015
 Kyle Bass Loses Round 1 Of IPR Attack Against Pharma/Biotech Patents
Dec
10
2019
 Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track
Jun
6
2023
 FDA’s New Dietary Supplement Ingredient Directory
Sep
1
2016
 Apotex v Wyeth Explores Structural Obviousness
May
9
2017
 Are Secret Sales Prior Art Under The AIA?
Dec
28
2012
 Top Ten Biotech IP Stories of 2012
Displaying 1 - 28 of 13404
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters